New wearable Patch Sensor Will Help In Diagnoses Of Heart Rhythm Disorder

New wearable Patch Sensor Will Help In Diagnoses Of Heart Rhythm Disorder

New wearable Patch Sensor Will Help In Diagnoses Of Heart Rhythm Disorder(representational Image)

New Delhi: Scientists have found a wearable patch, which acts like a sensor that can effectively improve the diagnosis rate for heart rhythm disorder without interfering with routine activities.  

Atrial fibrillation (Afib) disorder, is defined by increased or irregular heart rhythm that increases the risk of stroke, heart failure and other cardiovascular diseases.

The wearable patch approved by the US Food and Drug Administration (FDA) acts like a sensor and performs active electrocardiography (ECG) screening to detect irregular heart rhythm condition as well as recent heart attacks.

More people are receiving critical preventive therapies as a result to this device, which might have gone undiagnosed, said the researchers while emphasising the use of digital medicine technologies to identify undiagnosed Afib disorder in at-risk populations.

Steven Steinhubl, The Director of digital medicine at Scripps Translational Science Institute (STSI) in California, US said, "Our study shows an almost threefold improvement in the rate of diagnosis of AFib in the those actively monitored compared to usual care."

Also Read: Gene Editing Technique Promises To Treat Thalassemia In Womb

Steinhubl, who is also a professor at Scripps Research Institute in the US said," Timely diagnosis of AFib more effectively can enable the initiation of effective therapies and help reduce strokes and death."

The study was published in the journal JAMA, which included the data from 5,214 individuals for one year, with one third of the group being assigned to the monitored cohort and the rest being observational controls.

The sensor patch was self applied by the participants self-applied  for two weeks, after which they returned it for analysis.

Around six per cent of the group developed Afib and nearly three per cent among the controls developed the disease.

Steinhubl explained," This study demonstrates the utility of a digital approach not only to diagnosing asymptomatic AFib, but to the clinical research field as a whole."

(Inputs From News Agency IANS)

For more Lifestyle Stories Click Here

Support Our Credible Journalism By subscribing to dailyaddaa. For the latest news on dailyaddaa, like us on Facebook and follow us on Twitter